Skip to main content
. 2021 Sep 28;14(9):100578. doi: 10.1016/j.waojou.2021.100578

Table 2.

Composition of the most frequently used primary end-point scores for AIT Phase III studies: CSMS and TCS.

A) Symptom Score: CSMS + TCS
Conjunctival Symptoms Grittya feeling/itchy/red eyes
Watery eyes
Nasal Symptoms Blocked nose
Runny nose
Itchy nose
Sneezing
Each of the 6 symptoms will be scored using a 4-point severity scale
0 = No symptoms
1 = Mild symptoms (sign/symptom clearly present, but minimal awareness; easily tolerated)
2 = Moderate symptoms (definite awareness of sign/symptom that is bothersome but tolerable)
3 = Severe symptoms (sign/symptom that is hard to tolerate; causes interference with activities of daily living and/or sleeping).
B) Medication Score: Combined Symptom Medication Score (CSMS)
Step Relief medication Score
No relief medications used 0
1 Oral antihistamine/Ocular antihistamine 1
2 Intranasal corticosteroid with Step 1 medication(s) 2
3 Oral corticosteroids with Step 1 and Step 2 medications 3
Maximum daily Medication Score (dMS) 3
C) Medication Score: Total Combined Score (TCS)
Relief medication Score
No relief medications used 0
Oral antihistamine Each tablet taken corresponds to a score of 6 with a maximum daily score of 6
Ocular antihistamine Each drop corresponds to a score of 1.5 per eye with a maximum daily score of 6
Intranasal corticosteroid Each spray corresponds to a score of 2 with a maximum daily score of 8
Maximum daily Medication Score (dMS) 20
a

Gritty feeling is only applicable for the definition of TCS. CSMS = combined symptom medication score; TCS = total combined score